WIN378 Shows Six-Month Pharmacology as Phase III Begins

Evidence Source-gap catch-up · Published September 8, 2026 · Discovery September 8, 2026 · Importance 4/5 · Direction Positive Summary Windward Bio reported interim results from the randomized, double-blind Phase II portion of POLARIS-1 in uncontrolled moderate-to-severe asthma and initiated the seamless Phase III portion.…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *